QIAGEN demonstrates expanded bioinformatics workflows at ASHG; strong market adoption as researchers analyse genomic data on more than a quarter-million samples in secure private cloud Translational research in cancer and
Thermo Fisher Scientific Reports Third Quarter 2014 Results Third Quarter Highlights Grew adjusted earnings per share (EPS) by 32% to $1.71. Increased revenue by 31% to $4.17 billion. Expanded adjusted
